Physician profile
Scott L Baum
NPI 1841229218
$1,267.41
in general payments reported to CMS, 2019-2025
14 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $67.37 · 2021: $200 · 2022: $106 · 2023: $117 · 2024: $187 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $606.28 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.38 | 2019-2025 | |
| Telix Pharmaceuticals | $122.57 | 2022-2025 | Illuccix |
| Angiodynamics, INC. | $116.77 | 2019-2025 | Solero |
| Pharmacyclics LLC, An Abbvie Company | $57.58 | 2021-2023 | Imbruvica |
| Novartis Pharmaceuticals Corporation | $49.23 | 2021-2022 | |
| Stryker Corporation | $43.10 | 2024 | Omnicurve |
| Medtronic, INC. | $40.66 | 2021 | |
| Sirtex Medical INC | $34.05 | 2023-2024 | Sir-Spheres Microspheres |
| Teleflex LLC | $16.44 | 2022 | |
| Blue Earth Diagnostics | $15.88 | 2022 | |
| Covidien Lp | $13.52 | 2019 | |
| Boston Scientific Corporation | $11.77 | 2021 | |
| Medtronic USA, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.